Advertisement
Screener

Protalix BioTherapeutics, Inc. (PLX) Cash Flow Breakdown

Protalix BioTherapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Protalix BioTherapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $11.99M went out.
  • Fiscal year ended 2025-12-31: from investing, $2.37M went out.
  • Fiscal year ended 2025-12-31: from financing, $9.33M came in.
  • Fiscal year ended 2025-12-31: change in cash, $5.08M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$11.99M-$2.37M$6.81M$2.51M*-$5.08M
2024-12-31$8.67M$4.22M$3.63M-$20.42M*-$3.87M
2023-12-31-$1.32M-$16.71M$23.95M$712.00K*$6.52M
2022-12-31-$25.00M-$5.04M$8.24M-$21.87M
2021-12-31-$10.29M$18.92M$8.57M$3.50M*$20.72M
2020-12-31-$26.11M-$19.95M$4.87M$41.60M*$473.00K
2019-12-31-$19.36M-$883.00K-$20.02M
2018-12-31-$7.74M-$591.00K$0.00-$4.75M*-$13.36M
2017-12-31-$9.99M-$1.12M$0.00-$1.42M*-$12.12M
2016-12-31-$32.10M-$967.00K$14.00K$19.68M*-$13.09M
2015-12-31-$24.28M$39.39M$534.00K$6.10M*$21.61M
2014-12-31-$29.28M-$1.00M$46.00K-$31.63M
2013-12-31-$30.65M-$2.10M$112.00K$66.78M*$34.36M
2012-12-31$635.00K-$2.29M$1.23M$25.33M*$25.03M
2011-12-31-$23.57M-$5.87M$277.00K$20.65M*-$8.90M
2010-12-31-$38.46M-$7.99M$501.00K-$45.37M
2009-12-31$44.45M-$6.17M$293.00K$38.67M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$10.40M*-$3.63M*
2026-03-31$22.02M$4.22M$26.32M
2025-12-31$2.03M*-$1.11M*$0.00*
2025-09-30-$3.73M*-$504.00K*$0.00*
2025-06-30-$5.23M*-$438.00K*$3.95M*
2025-03-31-$5.06M-$312.00K$2.86M$2.21M*-$302.00K
2024-12-31$3.99M*-$15.32M*$3.63M*
2024-09-30$4.11M*$20.33M*
2024-06-30-$3.61M*-$180.00K*
2024-03-31$4.19M-$606.00K$3.58M
2023-12-31$3.60M*-$342.00K*$0.00*
2023-09-30-$6.89M*-$20.88M*$0.00*
2023-06-30$4.97M*-$222.00K*$9.72M*$712.00K*
2023-03-31-$3.00M$4.73M$14.23M$15.93M
2022-12-31-$2.61M*$4.95M*$4.08M*
2022-09-30-$9.20M*$5.91M*$1.52M*
2022-06-30-$7.36M*$357.00K*
2022-03-31-$5.83M-$16.26M-$22.10M
2021-12-31-$5.09M*$37.44M*$0.00*-$4.05M*
2021-09-30-$1.88M*$4.63M*$0.00*-$25.99M*
2021-06-30$6.52M*$7.54M*$0.00*
2021-03-31-$9.83M-$30.68M$8.57M$33.54M*$1.56M
2020-12-31-$7.55M*$7.59M*$4.65M*
2020-09-30-$3.60M*$7.80M*$4.47M*
2020-06-30-$7.83M*-$268.00K*-$1.26M*
2020-03-31-$7.12M-$35.08M$38.61M*-$3.63M
2019-12-31-$3.69M*$29.00K*
2019-09-30-$3.23M*-$446.00K*
2019-06-30-$5.17M*-$95.00K*
2019-03-31-$7.28M-$371.00K-$7.45M
2018-12-31-$4.00M*$84.00K*-$4.06M*
2018-09-30$13.64M*-$228.00K*$13.54M*
2018-06-30-$7.96M*-$119.00K*-$12.99M*
2018-03-31-$9.41M-$328.00K-$9.84M
2017-12-31$17.59M*-$34.00K*$17.68M*
2017-09-30-$10.54M*-$116.00K*$9.54M*-$1.05M*
2017-06-30-$8.62M*-$686.00K*-$4.24M*-$13.48M*
2017-03-31-$8.43M-$283.00K-$6.73M*-$15.26M
2016-12-31-$7.34M*-$242.00K*$14.00K*$19.68M*$11.96M*
2016-09-30-$3.44M*-$66.00K*$0.00*-$3.31M*
2016-06-30-$11.69M*-$366.00K*-$12.04M*
2016-03-31-$9.63M-$293.00K-$9.71M
2015-12-31-$3.86M*$39.90M*$0.00*$6.10M*$42.13M*
2015-09-30-$8.66M*-$169.00K*$0.00*-$8.99M*
2015-06-30-$5.35M*-$248.00K*-$4.72M*
2015-03-31-$6.42M-$99.00K-$6.81M
2014-12-31-$4.71M*-$169.00K*$3.00K*-$5.55M*
2014-09-30-$9.55M*-$267.00K*$12.00K*-$10.83M*
2014-06-30-$6.52M*-$195.00K*$0.00*-$6.55M*
2014-03-31-$8.34M-$370.00K$31.00K-$8.71M
2013-12-31-$4.74M*-$271.00K*$82.00K*-$5.00M*
2013-09-30-$8.22M*-$419.00K*$0.00*$66.93M*$58.27M*
2013-06-30-$8.11M*-$723.00K*-$8.74M*
2013-03-31-$9.59M-$689.00K-$10.16M
2012-12-31$1.82M*-$376.00K*$134.00K*$1.82M*
2012-09-30-$8.03M*-$819.00K*$10.00K*-$9.06M*
2012-06-30$13.12M*-$239.00K*$1.05M*$13.68M*
2012-03-31-$6.28M-$852.00K$36.00K$25.54M*$18.60M
2011-12-31-$6.61M*-$747.00K*$14.00K*-$7.56M*
2011-09-30-$8.15M*-$1.03M*$4.00K*-$9.49M*
2011-06-30-$4.82M*-$1.44M*$3.00K*-$6.17M*
2011-03-31-$3.99M-$2.65M$256.00K$20.68M*$14.33M
2010-12-31-$8.03M*-$1.07M*$342.00K*-$8.50M*
2010-09-30-$9.68M*-$1.38M*$132.00K*-$10.56M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95